| MIAB group | EUS-FNAB group | P value |
---|---|---|---|
Number of patients | 71 | 106 | Â |
Gender; male/female | 31/40 | 56/50 | n.s. (P = 0.23) |
Age; median & range | 62 (27–84) | 63 (27–87) | n.s. (P = 0.95) |
Lesion size (mm); median & range | 19.6 (8.8–48) | 20.0 (9–63) | n.s. (P= 0.096) |
Number of lesions in each gastric location |  |  | n.s. (P= 0.61) |
 Upper stomach | 40 | 66 |  |
 Middle stomach | 18 | 26 |  |
 Lower stomach | 13 | 14 |  |
Procedural time (min); median & range | 31.5 (9–160) | 21.0 (8–55) | P < 0.0001 |
Success rate of tissue sampling | 95.6% (68/71) | 86.8% (92/106) | P = 0.047 |
Diagnostic yield | 94.3% (67/71) | 79.2% (84/106) | P = 0.013 |
Complication rate | 0% (0/71) | 0% (0/106) | n.s (P = 1.0) |
Number of lesions of each histology type |  |  | n.s. (P = 0.053) |
GIST | 53.5% (38/71) | 60.4% (64/106) | Â |
 Leiomyoma | 25.3% (18/71) | 11.3% (12/106) |  |
 Schwannoma | 2.8% (2/71) | 3.8% (4/106) |  |
 Aberrant pancreas | 8.5% (6/71) | 2.8% (3/106) |  |
 Glomus tumor | 1.4% (1/71) | – |  |
 Lipoma | 1.4% (1/71) | – |  |
 Inflammatory change | 1.4% (1/71) | – |  |
 Renal cell carcinoma | – | 0.9% (1/106) |  |
Matching rate of pre- and post-operative diagnoses | 100% (35/35) | 100% (34/34) | n.s. (P = 1.0) |